Neuralink

The combined force of Neuralink's brain chips and Tesla Inc's (NASDAQ: TSLA) Optimus robot may soon be with us. What To Know: Elon Musk's brain-computer interface technology company Neuralink was cleared for in-human clinical trials earlier this year. In a...

Elon Musk is facing another round of allegations of securities fraud, and this time, it comes from a medical ethics group questioning Musk's statement on the death of monkeys at his biotech startup Neuralink. What Happened: Even as Musk claimed that no monkeys died due to Neuralink implants, a new...

Elon Musk's brain-computer interface company, Neuralink, has initiated recruiting its first test subjects for human trials aimed at assisting individuals with paralysis in controlling devices. Neuralink announced that it has obtained approval from an independent...

It’s been a whirlwind week in the world of artificial intelligence (AI). From investment trends to massive funding rounds, the AI sector is buzzing with activity. As companies ramp up their AI investments, some big names are making significant moves. Let’s dive into the top stories of...

Best known as the CEO of Tesla, Elon Musk also wears many other hats with titles of co-founder, owner and CEO pertaining to SpaceX, The Boring Company, Neuralink and social media platform X, formerly known as Twitter. One of the companies co-founded by Musk recently landed a funding round...

Tech billionaire Elon Musk has unveiled his latest venture, xAI, featuring a dream team of 12 co-founders recruited from industry giants like DeepMind, OpenAI, Google, and Microsoft.  Leading the charge is Musk himself, alongside advisor Dan Hendrycks...

Neuralink Corp., the brainchild of Elon Musk and a select group of scientists, is gearing up for human trials of its groundbreaking implantable brain chip.  The technological marvel, championed by the visionary tech CEO, promises to revolutionize humanity, and people are signing up through the...

The concept of smartphones and electric cars seemed like a pipe dream 20 years ago, but today, nearly 6.92 billion people, or 86.4% of the global population, have personal smartphones. Governments worldwide are moving toward a green future by encouraging the use of electric cars instead of vehicles...

In a significant leap for the field of neurotechnology, Neuralink, a tech startup co-founded by billionaire entrepreneur Elon Musk, recently obtained the Food and Drug Administration’s approval to commence trials implanting their revolutionary brain chips into human subjects. The firm's...

Billionaire investor Li Ka-Shing is funding a new technology that can potentially rival artificial intelligence (AI) by using brain cells blended with computers in a technology it calls DishBrain.  Don’t Miss: Why Jason Calacanis and Other Silicon Valley Elites Are Betting On This...

Former Google engineer and esteemed futurist Ray Kurzweil has made another bold prediction: Immortality is within reach for humans by 2030, thanks to the help of nanorobots. You read that right — humans could potentially live forever, according to Kurzweil. Don't Miss: Why Jason Calacanis and Other...

Neuralink, the brain implant startup backed by Elon Musk, is valued at $5 billion. That’s up from $2 billion just two years ago. What Happened: Recent purchases from investors triggered Neuralink's 150% leap. Backers anticipate a company announcement that U.S. regulators approve of a brain...

Elon Musk, the genius behind SpaceX and Tesla Inc., has declared that humanity must embrace the merging of man and machine if we hope to survive in a world dominated by artificial intelligence (AI).  In a 2018 appearance on the “Joe Rogan Experience,” Musk teased his company...

Anxiety is a prevalent and serious mental health disorder affecting millions of Americans. According to the National Institute of Mental Health, almost one-third of adults will experience an anxiety disorder at some point in their lives. For those with anxiety disorders, the symptoms can be...

Elon Musk’s brain-computer interface venture, Neuralink, announced the clearance for its first human clinical study this week. However, the response on social media was far from unanimous praise. While the news drew congratulations from Twitter’s premium users, a significant share of...